Caris Life Sciences, Inc. (49J)
Market Closed
31 Aug, 07:31
XDUS 
€
21. 40
-0.4
-1.8349%
€
- Market Cap
- P/E Ratio
- Div Yield
47 Volume
- Eps
€ 21.8
Previous Close Want to track 49J and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Caris Life Sciences, Inc. (49J) Statistics
Valuation metrics
Market Cap -
Enterprise value -368.59M
Trailing P/E (ttm) -4.16
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) -
Price/Book (mrq) 6.38
Enterprise Value/Revenue -0.45
Enterprise Value/EBITDA -4.41
Overview
Shares outstanding 282.65M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 77
Average volume (90 days) 26
Price summary
52-Week low 12.1
52-Week high 32.6
Beta -
50-Day moving average 15.62
200-Day moving average 21.66
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.66%
Operating margin -0.01%
Operational effectiveness
Return on assets -0.48%
Return on equity -0.93%
Income Statement
Revenue (ttm) 812.03M
Revenue per share (ttm) 4.86
Quarterly revenue growth (yoy) -0.26%
Gross profit (ttm) 539.17M
EBITDA 83.56M
Net income to common (ttm) -623.39M
Diluted EPS (ttm) -3.22
Quarterly earnings growth (yoy) 0.79%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 430.96M
Total Debt/Equity (mrq) 0.73
Current ratio (mrq) 7.05%
Book value per share (mrq) 2.1
Cash Flow
Cash flow statement 4.65M
Levered free cash flow (LFCF) -537.96M
